GenomiXVE3 Global
|
||||||
Related Products
|
||||||
About
BenevolentAI is an AI-enabled drug discovery platform and scientific technology company that unites advanced artificial intelligence, machine learning, and domain-specific science to accelerate the discovery, design, and development of new medicines for complex diseases by making sense of vast, diverse biomedical data and generating actionable scientific insights faster than traditional methods. Its proprietary Benevolent Platform ingests and harmonizes structured and unstructured biomedical information, including literature, genomics, clinical information, and multi-omics data, into a comprehensive knowledge graph, enabling scientists to reason across biological systems, generate hypotheses, predict novel drug targets, and design candidate molecules with higher confidence and lower failure rates.
|
About
GenomiX is a unified analytics platform built to manage the complexity of modern genomics research and clinical workflows. It supports large-scale sequencing data, integrates fragmented systems like LIMS and EHRs, and enables multi-omics analysis across DNA, RNA, and epigenetics. With its cloud-agnostic, container-native architecture, GenomiX ensures flexibility, compliance, and scalability for both research and healthcare environments. The platform streamlines workflows with support for popular engines like Nextflow, WDL, and Snakemake, while offering preconfigured bioinformatics pipelines. Advanced AI and ML integrations accelerate clinical interpretation and research insights. GenomiX also prioritizes security, ensuring GDPR, HIPAA, and NHS compliance while facilitating collaboration across institutions.
|
|||||
Platforms Supported
Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook
|
Platforms Supported
Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook
|
|||||
Audience
Researchers, biopharma teams, and drug discovery professionals requiring a solution to uncover biological insights, identify therapeutic targets, and accelerate the development of new medicines
|
Audience
Hospitals, biotech firms, and academic research centers aiming to modernize genomics workflows, achieve compliance, and scale personalized medicine initiatives.
|
|||||
Support
Phone Support
24/7 Live Support
Online
|
Support
Phone Support
24/7 Live Support
Online
|
|||||
API
Offers API
|
API
Offers API
|
|||||
Screenshots and Videos |
Screenshots and Videos |
|||||
Pricing
No information available.
Free Version
Free Trial
|
Pricing
No information available.
Free Version
Free Trial
|
|||||
Reviews/
|
Reviews/
|
|||||
Training
Documentation
Webinars
Live Online
In Person
|
Training
Documentation
Webinars
Live Online
In Person
|
|||||
Company InformationBenevolentAI
Founded: 2013
Luxembourg
www.benevolent.com
|
Company InformationVE3 Global
Founded: 2025
United Kingdom
www.ve3.global/solutions/ve3-genomics-accelerator-solution/
|
|||||
Alternatives |
Alternatives |
|||||
|
|
|
|||||
|
|
||||||
|
|
||||||
|
|
||||||
Categories |
Categories |
|||||
Integrations
No info available.
|
Integrations
No info available.
|
|||||
|
|
|